Background illustration for clinical trials search

Prostate Cancer Clinical Trials

Browse 764 prostate cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)

for
Prostate Cancer
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: Male

Age: 18 - 70+

Code: NCT06960798

Recruiting

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

for
Hormone-refractory Prostate Cancer
Location: Fairfax VA, Houston TX, Seattle WA, Orange CA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: Male

Age: 18+

Code: NCT05997615

Phase1, Recruiting

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

for
Castration-Resistant Prostate Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04693377

Recruiting

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

for
Metastatic Castration Resistant Prostate Cancer (mCRPC),
Location: Myrtle Beach SC, Nashville TN, Omaha NE, Irving TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT03460977

Phase1, Recruiting

Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patients and Their Partners

for
Prostate Cancer, Sexual Dysfunction, Physiological,
Location: Ottawa, Kingston, Toronto, Barrie, Winnipeg, Vancouver
Sponsor: University Health Network, Toronto

Sex: Male

Age: 18+

Code: NCT06877598

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness

for
Prostate Cancer
Location: New York NY, Baltimore MD, Seattle WA
Sponsor: Prostate Cancer Clinical Trials Consortium

Sex: Male

Age: 18+

Code: NCT04995198

Recruiting

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

for
Castration-Resistant Prostate Carcinoma,
Location: South Weymouth MA, Foxborough MA, Methuen MA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06632977

Phase2, Recruiting

Non-contrast MR Imaging for Whole Body Cancer Detection and Characterization

for
Prostate Cancer
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: Male

Age: 18+

Code: NCT03440554

Recruiting

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

for
Breast Cancer, Colorectal Cancer, Pancreas Cancer,
Location: Kingston, Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05403177

Recruiting

Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance

for
Prostate Cancer Patients on Active Surveillance
Location: New York NY
Sponsor: Ashutosh Kumar Tewari

Sex: Male

Age: 18+

Code: NCT06343077

Phase2, Recruiting

ComCancer: Use of Let's Discuss Health Website by Patients With Prostate Cancer Undergoing Radiation Oncology Treatment

for
Prostatic Neoplasms, Psychological Distress,
Location: Quebec, Montreal, Laval
Sponsor: Ciusss de L'Est de l'Île de Montréal

Sex: Male

Age: 18+

Code: NCT05787145

Recruiting

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

for
Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer,
Location: Springdale AR
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT05415098

Phase1, Recruiting

Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer

for
Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma,
Location: Sacramento CA
Sponsor: Mamta Parikh

Sex: Male

Age: 19+

Code: NCT02935205

Phase1, Phase2, Recruiting

Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC

for
Metastatic Castration-resistant Prostate Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06100705

Phase2, Recruiting

Prostate Cancer Genetic Risk Evaluation and Screening Study

for
Prostatic Neoplasm, Prostate Cancer, BRCA2 Mutation,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: Male

Age: 35 - 70+

Code: NCT05129605

Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

for
Oncology, Breast Cancer, Prostate Cancer, Gynecologic Cancer,
Location: Toronto, Pittsburgh PA, Milwaukee WI, Houston TX
Sponsor: UMC Utrecht

Sex: All

Age: 18+

Code: NCT04075305

Recruiting

Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer

for
Prostate Cancer
Location: Toronto, London
Sponsor: University Health Network, Toronto

Sex: Male

Age: 18+

Code: NCT05328505

Recruiting

SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization

for
Prostate Cancer, Advanced Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18 - 70+

Code: NCT06389097

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

for
Advanced Metastatic Castration Resistant Prostate Cancer
Location: Fairfax VA, Houston TX, San Antonio TX, Spokane WA,
Sponsor: Shenzhen Ionova Life Sciences Co., Ltd.

Sex: Male

Age: 18+

Code: NCT06609005

Phase1, Phase2, Recruiting

Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

for
Prostate Cancer (Adenocarcinoma), Metastatic Prostate Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Male

Age: 18+

Code: NCT06616597

Phase2, Recruiting